Download presentation
Presentation is loading. Please wait.
Published byThomasine Baker Modified over 6 years ago
1
The Orphan Drug Act and the Development of Stem Cell-Based Products for Rare Diseases
Scott N. Freeman, Kathryn A. Burke, Menfo A. Imoisili, Timothy R. Coté Cell Stem Cell Volume 7, Issue 3, Pages (September 2010) DOI: /j.stem Copyright © 2010 Elsevier Inc. Terms and Conditions
2
Figure 1 Orphan Product Applications, Designations, and Marketing Approvals and Stem Cell-Based Product Orphan Designations (A) The quantities of orphan product applications, designations, and approvals collectively from 1983–2009 stratified by year class intervals. (B) Stem cell-based product orphan designations by year from 1983–2009. Cell Stem Cell 2010 7, DOI: ( /j.stem ) Copyright © 2010 Elsevier Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.